Single Use System in Biopharma Manufacturing Market
Equipment for biopharmaceutical manufacture that is intended to be used just once before being discarded is referred to as single use systems (SUS). Single-use technologies provide a very effective and economical method of producing biopharmaceuticals while significantly improving the product quality. Worldwide, biopharmaceutical businesses employ small- and large-scale bioreactors to produce pharmaceuticals and vaccines utilising single-use systems. Single-use technologies offer answers to the bioprocessing problems involved in the creation and production of biopharmaceuticals. Additionally, single-use systems (SUS) are being employed more often in place of stainless-steel equipment in the production of biopharmaceuticals.
By the end of 2022, the market for single-use systems in biopharma production is anticipated to be worth US$8,490.8 Mn.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5228
During the projected period, a rise in medicine and vaccine demand across the globe is anticipated to accelerate the growth of the global single use system in biopharma manufacturing market. For instance, the need for safe, effective medications and vaccines is rising as a result of biopharmaceuticals’ capacity to cure diseases that were previously incurable. Rockefeller received a global exclusive licence from Bristol Myers Squibb in February 2021 to create, produce, and market a new monoclonal antibody (mAb) dual treatment that neutralises the SARS-CoV-2 virus for COVID-19 treatment or prophylaxis.
The global single use system in biopharma manufacturing market is predicted to provide participants lucrative development possibilities due to the rise in demand for biopharmaceutical goods. In order to offer mass spectral data on pharmacological compounds, associated analytes, and cell culture medium, Waters Corp. and Sartorius partnered in October 2021 to install the BioAccord LC-MS System from Waters as a new bioprocess analyzer with data connection to Sartorius’ Ambr bioreactor systems. This will significantly increase the accuracy, speed, and efficiency of processes ranging from clone selection to bioprocess optimization.
The single use system’s expansion in the biopharma manufacturing sector is predicted to be hampered by qualifying concerns relating to extractable & leachable. The quality of the biological product may suffer as a result of the extractable and leachable chemicals combined with the finished product. Components that can be extracted or leached have the potential to be harmful to patients’ health and product quality. Because of this, biopharma products need to be thoroughly evaluated throughout production and storage.
Regarding the current COVID-19 situation, single-use technology enables quick development and production of vaccines and treatments. The COVID-19 outbreak was a turning point for single-use systems, with the demand for disposable and adaptable technology for industrial-scale manufacturing significantly rising.
Due to their dependability and purity, DuPont Liveo Healthcare Solutions have been chosen by manufacturers all over the world in the race to make COVID-19 vaccines. Liveo solutions have had an influence on the global effort to combat the COVID-19 pandemic, from being utilised in the collection of buffer and active prior to COVID-19 vaccine filtration to being used in single-use vaccination systems.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5228
The single use system in biopharma manufacturing market was valued at US$ 7,030.0 Mn in 2021 and is anticipated to grow at a CAGR of 20.8% between 2022 and 2028 to reach US$ 26,450.3 Mn.
The 1000-2000L segment of bioreactors held the majority of the market share in terms of value in the global single use system in biopharma manufacturing market in 2021, accounting for 58.3% of the market. Increasing product approval and the introduction of new products are anticipated to drive segment growth over the forecast period.
The single use system in biopharma manufacturing market is anticipated to rise as expenditures in drug and vaccine development increase. To develop and sell Takeda’s vaccine candidate, HIL-214, Frazier Healthcare and Takeda Pharmaceutical collaborated in July 2021 to establish HilleVax, a biopharmaceutical firm (previously TAK-214).
The ability of biopharmaceuticals to heal diseases that were previously incurable is anticipated to fuel demand for single-use systems in the biopharma manufacturing industry. Biopharmaceuticals are often utilised to treat inflammatory, autoimmune, and chronic viral hepatitis illnesses as well as cancer. Therefore, demand for biopharmaceuticals is rising along with the burden of disease.
Sartorius AG, Getinge AB, Entegris, Rentschler Biopharma SE, Pall Corporation, Kühner AG, Eppendorf, Danaher Corporation, Corning Incorporated, Merck KgaA, ThermoFisher Scientific, Lonza, and PBS Biotech Inc. among others, are significant market participants in the single use system in biopharma manufacturing market.
ThermoFisher Scientific committed around $100 million in September 2021 to build a specialised facility in the United States to produce single-use technologies (SUT) products.
In order to market the RoSS platform, Pall Corporation and Single Use Support GmbH established a strategic agreement in December 2020. This cooperation will improve Pall’s integrated solutions and increase the RoSS platform’s accessibility for Biopharma clients worldwide.
The introduction of the new vessel for their Ambr 250 modular benchtop automated micro bioreactor system was announced by Sartorius Stedim Biotech (SSB) in June 2019. Launch of the Ambr 250 Modular Bioreactor Vessel for Cell and Gene Therapy Uses
The Study Objectives are:
✔️ A comprehensive insight into key players operating in the Single Use System in Biopharma Manufacturing Market and their corresponding data.
✔️ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔️ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔️ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔️ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5228
Reasons to buy this Single Use System in Biopharma Manufacturing Market Report:
✅️ It attempts an analysis of the competing scenario.
✅️ The current and exceptional product revenue market.
✅️ An in-depth data on the regional investigation and competitive landscape structure.
✅️ It benefits in creating an awareness of the important key product segments.
✅️ The marketing strategies, opportunities, and development factors are explained.
✅️ Single Use System in Biopharma Manufacturing market size estimation and recent advancements in the industry are explained.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Single Use System in Biopharma Manufacturing Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Single Use System in Biopharma Manufacturing Industry Impact
Chapter 2 Global Single Use System in Biopharma Manufacturing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Single Use System in Biopharma Manufacturing (Volume and Value) by Type
2.3 Global Single Use System in Biopharma Manufacturing (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Single Use System in Biopharma Manufacturing Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Single Use System in Biopharma Manufacturing Market Analysis
Chapter 6 East Asia Single Use System in Biopharma Manufacturing Market Analysis
Chapter 7 Europe Single Use System in Biopharma Manufacturing Market Analysis
Chapter 8 South Asia Single Use System in Biopharma Manufacturing Market Analysis
Chapter 9 Southeast Asia Single Use System in Biopharma Manufacturing Market Analysis
Chapter 10 Middle East Single Use System in Biopharma Manufacturing Market Analysis
Chapter 11 Africa Single Use System in Biopharma Manufacturing Market Analysis
Chapter 12 Oceania Single Use System in Biopharma Manufacturing Market Analysis
Chapter 13 South America Single Use System in Biopharma Manufacturing Market Analysis
Chapter 14 Company Profiles and Key Figures in Single Use System in Biopharma Manufacturing Business
Chapter 15 Global Single Use System in Biopharma Manufacturing Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027